Pf-04531083

DB12468InvestigationalSmall molecule

Pf-04531083 has been investigated for the treatment of Pain and Chronic Pain.

Mechanism: Pharmacologically active on Sodium channel protein type 10 subunit alpha
Curator reviewed
Formula / weight: C₁₇H₁₆ClN₅O₂ · 357.8 g/mol (avg)
Code names: Pf-04531083

Resolves to

Compound

Structure

InChIKeyZRJGMDIPCQOGNI-UHFFFAOYSA-NSMILESCOC1=CC=C(Cl)C(=C1)C1=CC=C(NC(=O)C2=CC=NN2C)N=C1N

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pf-04531083, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.